Very happy to be one of the first contributors for a new journal led by Prof. Peter Taylor, touchREVIEWS in RMD, with an Editorial on the selectivity of JAK inhibitors in rheumatoid arthritis lnkd.in/g8jqrQZy lnkd.in/gyqgQE7J

lnkd.in/g_4UbJjv

lnkd.in/ggiDy28v

AVOID THE WEEKEND! Study of high-impact rheumatology journals (Rheumatology, J Rheum, & Seminars A&R) shows higher risk of "desk rejections" by editor (avoiding peer review) for manuscripts submitted Saturday (OR 1.23) or Sunday (OR 1.13) bit.ly/3MsGU0K

Apparemment, il vaut mieux profiter de son week-end que soumettre des articles scientifiques à une revue de rhumatologie... lnkd.in/gFyCA9M3 lnkd.in/g8_k6n35

Please to share this Editorial published in Joint Bone Spine discussing recent data related to the safety profile of JAKi in rheumatoid arthritis lnkd.in/eEFESPHU

Happy to share this review on the management of inadequate response to initial anti-TNF therapy in RA! lnkd.in/emdChsaZ

It’s Rheumatoid Arthritis Awareness Week (#RAAW) 12-17 Sept! Learn more about what’s being done to help fight RA: ow.ly/Ehtb50KA7ls #RAFactOrFiction

It’s Rheumatoid Arthritis Awareness Week (#RAAW) 12-17 Sept! Learn more about what’s being done to help fight RA: ow.ly/Ehtb50KA7ls lnkd.in/eqcCxXTd

Happy to share this beautiful review led by Vincent Di Martino "Busting the myth of methotrexate chronic hepatotoxicity" published in Nature Reviews Rheumatology lnkd.in/eTut6RuF

Need to be less scared about the use of MTX, considering liver disease! NatRevRheumatol THX! nature.com/articles/s4158…

#Methotrexate ➡️Unlikely that MTX alone capable of inducing chronic #liver disease ➡️Risk of MTX-induced liver injury primarily acute in nature ➡️Cumulative dose has no predictive value for fibrosis 👉🏽nature.com/articles/s4158… via NatRevRheumatol

RMD patients who receive anti-IL6 agents prior to SARS-CoV-2 infection have less severe COVID-19! Reassuring data from the French RMD COVID-19 cohort lnkd.in/eCGaR9D9

lnkd.in/etbH-AFv

Great review article in NEJM on #rheumatoid arthritis. Our understanding of the disease and options for management have come such a long way!

New download avaialble! VTE Risks and JAK inhibition bit.ly/3YS5zSC

Happy to share with you this study on difficult to treat rheumatoid arthritis recently published in rheumatology lnkd.in/eGehMx2R

Really happy to share with you the recommendations of the Société Française de Rhumatologie for assessing the risk of cardiovascular disease (CVD) and venous thromboembolism (VTE) before the initiation of targeted therapies for chronic inflammatory rheuma…lnkd.in/e9NGhNdM

Rheum Research in Brief Profiling of Rheumatic Disease–Evaluated JAK Inhibitors In A&R loom.ly/z3Ee0iY

Preclinical data suggest caution when applying CD19-targeted CAR-T cells in patients with systemic sclerosis with associated interstitial lung disease In A&R loom.ly/lJUpn3I by Avouac Jérôme et al Image: CD19 CAR-T cells worsen lung fibrosis in Fra-2 Tg mice